Postpartum Depression (PPD) Market
Postpartum Depression (PPD) Market Size, Share & Trends Analysis Report
Postpartum Depression (PPD) Market Size, Share, Statistics & Trends Analysis Report By Types (Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Others), By Treatment (Psychotherapy, Cognitive Behavioral Therapy, Interpersonal Therapy, Others, Medication, Anti-psychotic, Others, Supplements, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 2854
Number of pages : 302
Published Date : Feb 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Segmentation For Postpartum Depression (PPD) market:
By Types:
- Postpartum Blues
- Postpartum Anxiety
- Postpartum Obsessive Compulsive Disorder
- Postpartum Panic Disorder
- Postpartum Post-Traumatic Stress Disorder
- Postpartum Psychosis
- Others
By Treatment:
- Psychotherapy
- Cognitive Behavioral Therapy
- Interpersonal Therapy
- Others
- Medication
- Anti-psychotic
- Others
- Supplements
- Others
By Route of Administration:
- Oral
- Parenteral
- Others
By End-Users:
- Hospitals
- Specialty Clinics
- Homecare
- Others
Key Players For Postpartum Depression (PPD) market:
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.
- Sanofi (France)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Bayer AG (Germany)
- Merck & Co. Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Eli Lilly and Company (US)
- Cipla Inc. (US)
- Aurobindo Pharma (India)
- Lupin (India)
- Accord Healthcare (US)
- Sun Pharmaceutical Industries Ltd.
- Bausch Health Companies Inc. (Canada)
- Alvogen (US)
- Intas Pharmaceuticals Ltd. (India)
- SHIONOGI & Co. Ltd. (Japan)
SUMMARY
Segments
Segmentation For Postpartum Depression (PPD) market:
By Types:
- Postpartum Blues
- Postpartum Anxiety
- Postpartum Obsessive Compulsive Disorder
- Postpartum Panic Disorder
- Postpartum Post-Traumatic Stress Disorder
- Postpartum Psychosis
- Others
By Treatment:
- Psychotherapy
- Cognitive Behavioral Therapy
- Interpersonal Therapy
- Others
- Medication
- Anti-psychotic
- Others
- Supplements
- Others
By Route of Administration:
- Oral
- Parenteral
- Others
By End-Users:
- Hospitals
- Specialty Clinics
- Homecare
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players For Postpartum Depression (PPD) market:
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.
- Sanofi (France)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Bayer AG (Germany)
- Merck & Co. Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Eli Lilly and Company (US)
- Cipla Inc. (US)
- Aurobindo Pharma (India)
- Lupin (India)
- Accord Healthcare (US)
- Sun Pharmaceutical Industries Ltd.
- Bausch Health Companies Inc. (Canada)
- Alvogen (US)
- Intas Pharmaceuticals Ltd. (India)
- SHIONOGI & Co. Ltd. (Japan)
